Are you Dr. Kim?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 24 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1301 N Rose Dr
Placentia, CA 92870Phone+1 714-993-2000
Summary
- Dr. Youn Kim, MD is a board certified anesthesiologist in Placentia, California. He is currently licensed to practice medicine in California, Pennsylvania, and Massachusetts. He is affiliated with Placentia-Linda Hospital.
Education & Training
New York Medical College at Metropolitan HospitalResidency, Anesthesiology, 1982 - 1984
Montefiore - Mount Vernon HospitalInternship, Transitional Year, 1981 - 1982
Korea University College of MedicineClass of 1976
Certifications & Licensure
CA State Medical License 1989 - 2021
MA State Medical License 1982 - 1999
PA State Medical License 1984 - 1990- American Board of Anesthesiology Anesthesiology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2004-2014
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
Clinical Trials
- Monoclonal Antibody Therapy in Treating Patients With Advanced or Recurrent Lymphoma Start of enrollment: 2001 Apr 01
- Autologous Followed by Non-myeloablative Allogeneic Transplantation for Non-Hodgkin's Lymphoma Start of enrollment: 2007 Jan 01
- Forodesine in the Treatment of Cutaneous T-Cell Lymphoma Start of enrollment: 2007 Jul 01
- Join now to see all
Publications & Presentations
PubMed
- 101 citationsRecombinant human relaxin in the treatment of systemic sclerosis with diffuse cutaneous involvement: a randomized, double-blind, placebo-controlled trial.Dinesh Khanna, Philip J. Clements, Daniel E. Furst, Joseph H. Korn, Michael H. Ellman
Arthritis and Rheumatism. 2009-04-01 - 485 citationsLong-term Outcome of 525 Patients With Mycosis Fungoides and Sézary Syndrome: Clinical Prognostic Factors and Risk for Disease ProgressionYoun H. Kim, Howard L. Liu, Serena Mraz-Gernhard, Anna M. Varghese, Richard T. Hoppe
Archives of Dermatology. 2003-07-01 - 378 citationsIn Situ Vaccination With a TLR9 Agonist Induces Systemic Lymphoma Regression: A Phase I/II StudyJoshua Brody, Weiyun Z. Ai, Debra K. Czerwinski, James A. Torchia, Mia A. Levy
Journal of Clinical Oncology. 2010-10-01
